• Interpretation of Global Strategy for the Diagnosis, Treatment, Management and Prevention of Chronic Obstructive Pulmonary Disease 2024 Report

    Subjects: Medicine, Pharmacy submitted time 2024-07-02 Cooperative journals: 《中国全科医学》

    Abstract: Global initiative for chronic obstructive lung disease (GOLD) 2024 report was released on November 13th, 2023. In general, the definition, diagnosis, assessment, and therapy of chronic obstructive pulmonary disease (COPD) are the same as GOLD 2023, with corresponding content added in ten aspects, including the expansion of the information about PRISm, a new section on hyperinflation, further clarification about pre-bronchodilator spirometry, a new section on screening for COPD in targeted populations, the update of blood eosinophil count, the update of interstitial lung abnormalities, the revision of the section on smoking cessation, the update of vaccination recommendations for people with COPD, the expansion of managing inhaled therapy, and the addition of pharmacotherapies for smoking cessation. The article introduces and interprets the new contents.

  • Current status of implementation of patient involvement in health care to improve quality of care among chronic obstructive pulmonary disease:a scoping review

    Subjects: Medicine, Pharmacy >> Preventive Medicine and Hygienics submitted time 2024-05-27 Cooperative journals: 《中国全科医学》

    Abstract: Background  In patient involvement,patients are transforming from mere recipients to collaborators in medical services by integrating their experiences and needs throughout the entire healthcare process into medical practice. This aims to enhance the effectiveness,efficiency,and quality of healthcare services. However,the implementation of proven patient#2;centered strategies for patient involvement in the quality improvement among chronic obstructive pulmonary disease(COPD)in our country remains to be explored.Objective  This scoping review systematically reviews and analyzes the existing strategies for patient involvement among patients with COPD to provide a reference for implementation that in China.Methods  Employing the scoping review guidelines of Joanna Briggs Institute in Australia as the methodological framework,the relevant studies on patient involvement among patient with COPD were searched by computer on PubMed,Embase,Cochrane Library,CNKI,Wanfang Database,China Biology Medicine disc. A thematic analysis was methodically applied to distill and synthesize findings. Results  A total of 37 articles were included in this review. The categorization of patient involvement was divided into three types:direct involvement in medical care,organizational-level,and clinical research. Based on the intensity of involvement,categories were further classified into three levels:consultation,engagement,and collaborative leadership. A nine-category matrix of patient involvement behaviors was constructed through intensity and type. The implementation of COPD patient engagement was primarily reflected in five categories encompassing eight behaviors,including:integration in direct medical care(patients expressing their preferences and wishes regarding treatment plans);consultation at the organizational management level(assessing patient treatment experiences and organizing discussions around patients' concerns);as well as involvement in clinical research,including consultation(listening to patient needs)and engagement(expressing preferences and wishes for interventions,involved in the development of assessment tools,and in discussions about research design and implementation). Assessing patient treatment experiences(10 articles,27.03%)and expressing patient preferences and wishes regarding interventions(10 articles,27.03%)were the two most frequently implemented behaviors of patient involvement in COPD. Conclusion  There are numerous measures for patient involvement in the improvement of medical quality,but there is still limited practice in the field of COPD. Very few studies have assessed the impact of patient involvement on clinical outcomes and quality of life,indicating that the practice of patient involvement in China requires further exploration.

  • Interpretation of Global Strategy for the Diagnosis,Treatment,Management and Prevention of Chronic Obstructive Pulmonary Disease 2024 Report

    Subjects: Medicine, Pharmacy >> Clinical Medicine submitted time 2024-01-16 Cooperative journals: 《中国全科医学》

    Abstract: Global initiative for chronic obstructive lung disease(GOLD)2024 report was released on November 13th,2023. In general,the definition,diagnosis,assessment,and therapy of chronic obstructive pulmonary disease(COPD) are the same as 2023 年 GOLD,with corresponding content added in ten aspects,including the expansion of the information about PRISm,a new section on hyperinflation,further clarification about pre-bronchodilator spirometry,a new section on screening for COPD in targeted populations,the update of blood eosinophil count,the update of interstitial lung abnormalities, the revision of the section on smoking cessation,the update of vaccination recommendations for people with COPD,the expansion of managing inhaled therapy,and the addition of pharmacotherapies for smoking cessation. The article introduces and interprets the new contents.